Oral vs Topical Finasteride for Trans Women
    Transgender 8/14/2024

    From the encyclopedia
    Cyproterone →

    a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

    Estradiol →

    an estrogen promoting hair regrowth more commonly used in women

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💧 Finoxidil (topical)
    💊 Cyproterone (oral) 12.5mg Monday/Wednesday/Friday
    💊 Estradiol (oral) 2mg daily
    the tone is 😐 neutral.

    Other terms

    A user is using a Finoxidil topical spray and is curious if oral Finasteride would be more effective, considering they are already on a DHT blocker called Cyproterone. They are concerned about the potential impact of oral Finasteride on their transition.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Updates in Treatment for Androgenetic Alopecia

      research Updates in Treatment for Androgenetic Alopecia

      January 2025 in “Annals of Dermatology”
      This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.
      Alopecia: Managing the Basics

      research Alopecia: managing the basics

      July 2015 in “Cambridge University Press eBooks”
      The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.
      Medical Treatment of Alopecia

      research Medical Treatment of Alopecia

      October 2018 in “InTech eBooks”
      This article reviews various treatments for alopecia, highlighting that minoxidil, finasteride, PRP therapy, and hair transplants are the most commonly used options, but it reports no new clinical results.

      research Female pattern hair loss: therapeutic update

      March 2023 in “Anais Brasileiros De Dermatologia”
      This article reviews treatment options for female-pattern hair loss, noting the limited evidence for most therapies and emphasizing that topical minoxidil remains the only well-supported option despite a significant non-response rate.